Mineral

    Lithium Orotate

    Lithium Orotate

    TL;DR

    Lithium orotate is a low-dose lithium salt sold over the counter for mood and irritability. Every controlled mood trial has used prescription-strength lithium carbonate; the microdoses in supplements have no randomized human evidence at all.

    Ideal For

    • People discussing low-dose lithium with a prescriber who will monitor renal and thyroid function

    Avoid If

    • You have bipolar disorder and are self-treating instead of seeking prescription care
    • You have kidney disease or thyroid disease
    • You take NSAIDs, ACE inhibitors, ARBs or thiazide diuretics regularly
    • You are pregnant — lithium is associated with cardiac malformations

    Frequently Asked Questions

    Overview

    Lithium is a legitimate and effective psychiatric drug — for bipolar disorder it remains the best-evidenced mood stabilizer and the only one with a documented anti-suicide effect. Lithium orotate is a different proposition. It supplies roughly 3.8 mg of elemental lithium per 120 mg tablet, against therapeutic carbonate doses delivering 150-300 mg of elemental lithium daily. Marketing claims that orotate is a superior carrier that concentrates lithium in brain tissue trace back to unreplicated 1970s animal work by Hans Nieper and have never been demonstrated in humans. What genuinely exists is epidemiology: multiple ecological studies find lower suicide rates in regions with higher naturally occurring lithium in drinking water, at doses in the microgram range. That is suggestive of a population-level effect but cannot establish that a supplement changes an individual's outcome. There is also a small, low-quality literature on low-dose lithium slowing cognitive decline. Bottom line: if you have a mood disorder, the evidence supports prescription lithium with proper monitoring — a supplement that provides a fraction of the dose without blood-level checks is not a substitute, and self-treating bipolar disorder with it is dangerous.

    How It Works

    • Inhibits GSK-3 beta, a shared node in mood-stabilizer and neuroprotection pathways
    • Depletes inositol via inhibition of inositol monophosphatase, blunting overactive second-messenger signalling
    • Upregulates BDNF and neuroprotective proteins in preclinical models
    • Orotate is a metabolic intermediate with no proven role in enhancing lithium transport in humans

    Benefits & Outcomes

    No linked outcomes yet. Research is ongoing.

    Supporting Research
    6 studies

    The association between lithium in drinking water and neuropsychiatric outcomes: A systematic review and meta-analysis from across 2678 regions containing 113 million people

    Score: 8/10
    2021
    meta_analysis

    Eyre-Watt B, Mahendran E, Suetani S

    Associations between lithium in drinking water and neuropsychiatric outcomes were small, inconsistent and highly heterogeneous.

    View source

    Standard and trace-dose lithium: A systematic review of dementia prevention and other behavioral benefits

    Score: 7/10
    2014
    systematic_review

    Mauer S, Vergne D, Ghaemi SN

    Evidence for trace-dose lithium is limited and largely ecological, whereas standard-dose lithium carries the stronger dementia-prevention signal.

    View source

    Lithium toxicity from an Internet dietary supplement

    Score: 3/10
    2007
    case_study
    n=1

    Pauze DR, Brooks DE

    A patient developed lithium toxicity after ingesting an over-the-counter lithium orotate supplement.

    View source

    Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies

    Score: 7/10
    2020
    meta_analysis

    Memon A, Rogers I, Fitzsimmons SMDD

    Higher lithium levels in drinking water were associated with lower suicide mortality across ecological studies.

    View source

    Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

    Score: 7/10
    2011
    rct
    n=45

    Forlenza OV, Diniz BS, Radanovic M

    Low-dose lithium improved attention and reduced CSF phosphorylated tau, but did not improve the primary cognitive outcomes.

    View source

    Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease

    Score: 5/10
    2013
    rct
    n=113

    Nunes MA, Viel TA, Buck HS

    Microdose lithium was associated with stable MMSE scores over 15 months while the control group declined.

    View source

    Safety Information

    Potential Side Effects

    Nausea, tremor, thirst and increased urination. Long-term lithium exposure at any dose can affect thyroid and kidney function; supplement users get none of the monitoring prescription patients receive.

    Contraindications

    Pregnancy, breastfeeding, renal impairment, untreated thyroid disease, dehydration.

    Drug Interactions

    • NSAIDs — raise lithium levels
    • Thiazide diuretics — raise lithium levels
    • ACE inhibitors and ARBs — raise lithium levels
    • SSRIs — serotonin syndrome risk at therapeutic lithium levels

    Pregnancy & Breastfeeding

    Pregnancy: likely_unsafe

    Breastfeeding: likely_unsafe

    Dosage Guidelines

    Dosage Used in Studies

    Consult healthcare provider

    Forms Compared

    Food & Timing

    Taken with food; splitting doses reduces nausea.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.